Stockholders' Equity

12 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders' Equity

Stock Repurchase Program. The Company’s Board of Directors has approved various authorizations under the Company’s stock repurchase program to repurchase shares of its common stock, including an approval on July 27, 2022, to increase its stock repurchase authorization by $1,200,000 (collectively, the stock repurchase program). As of March 31, 2023, the aggregate remaining approved amount under the stock repurchase program is $1,356,635. The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be suspended at any time at the Company’s discretion. Stock repurchase activity under the Company’s stock repurchase program was as follows:

	Years Ended March 31,
	2023		2022		2021
Dollar value of shares repurchased (1) (2)	$	297,372	$	356,653	$	99,147
Total number of shares repurchased (3)	928,262		1,043,554		307,080
Weighted average price paid per share	$	320.35	$	341.77	$	322.87

(1) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs associated with the program.

(2) May not calculate on rounded dollars.

(3) All share repurchases were made pursuant to the Company's publicly announced stock repurchase program in open-market transactions.

Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the consolidated balance sheets are as follows:

	As of March 31,
	2023		2022
Cumulative foreign currency translation loss	$	(39,035)	$	(24,955)